Stock listing

LYEL Stock Price, News, Filings & Events — Lyell Immunopharma, Inc.

Selected listing: LYEL · NASDAQ · USD · US

This page tracks Lyell Immunopharma, Inc.'s LYEL:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LYEL:NASDAQ. LYEL:NASDAQ is the stock-level entry point for investors researching Lyell Immunopharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lyell Immunopharma, Inc. is a public company traded under the ticker LYEL in the American market. The company has a market capitalization of approximately $309.5 million. Lyell focuses on developing innovative immunotherapies for cancer treatment.